摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3-butylphenyl)-4,5-dichloropyridazin-3(2H)-one | 1035450-58-8

中文名称
——
中文别名
——
英文名称
2-(3-butylphenyl)-4,5-dichloropyridazin-3(2H)-one
英文别名
2-(3-butylphenyl)-4,5-dichloropyridazin-3-one
2-(3-butylphenyl)-4,5-dichloropyridazin-3(2H)-one化学式
CAS
1035450-58-8
化学式
C14H14Cl2N2O
mdl
——
分子量
297.184
InChiKey
FQBCISABIGZJSB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    32.7
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • PYRIDAZINONES AND FURAN-CONTAINING COMPOUNDS
    申请人:Djaballah Hakim
    公开号:US20100210649A1
    公开(公告)日:2010-08-19
    The present invention is directed to pyridazinone compounds of formula (I) and furan compounds of formula (II), pharmaceutical compositions of compounds of formula (I) and (II), kits containing these compounds, methods of syntheses, and a method of treatment of a proliferative disease in a subject by administration of a therapeutically effective amount of a compound of formulae (I) or (II). Both classes of compounds were identified through screening of a collection of small molecule libraries.
    本发明涉及式(I)的吡啶二酮化合物和式(II)的呋喃化合物,以及式(I)和(II)化合物的制药组合物、包含这些化合物的试剂盒、合成方法,以及通过给予式(I)或(II)化合物的治疗有效量来治疗受体内增生性疾病的方法。这两类化合物是通过筛选小分子库的集合而确定的。
  • NANOPOROUS AND MICROPOROUS SOLVOGELS AND NONOLATEXES BY MICROEMULSION POLYMERIZATION
    申请人:Yan Feng
    公开号:US20090176915A1
    公开(公告)日:2009-07-09
    The present invention relates to microemulsions of immiscible fluids stabilized by reactive ionic liquid surfactant wherein the ionic liquid surfactant has a melting point less than 80° C. The invention also relates to composite materials comprising a copolymer of ethylenically reactive species, wherein one of the species is a reactive ionic liquid surfactant having a melting point less than 80° C., and wherein the material also comprises non-reactive Class I fluid. The invention further relates to methods for synthesizing the composite materials comprising preparing a microemulsion of immiscible Class I fluid and Class II fluid stabilized by reactive ionic liquid surfactant wherein the ionic liquid surfactant has a melting point less than 80° C., and polymerizing the microemulsion to form a composite material.
    本发明涉及由具有熔点低于80°C的反应性离子液体表面活性剂稳定的不相容流体的微乳液。本发明还涉及复合材料,包括乙烯基反应性物种的共聚物,其中一种物种是具有熔点低于80°C的反应性离子液体表面活性剂,并且该材料还包括非反应性的一类流体。本发明还涉及制备复合材料的方法,包括制备由具有熔点低于80°C的反应性离子液体表面活性剂稳定的不相容的一类流体和二类流体的微乳液,并聚合微乳液以形成复合材料。
  • Pyridazinones and furan-containing compounds
    申请人:Sloan-Kettering Institute For Cancer Research
    公开号:EP2518063A1
    公开(公告)日:2012-10-31
    The present invention is directed to pyridazinone compounds of formula (I) and furan compounds of formula (II), pharmaceutical compositions of compounds of formula (I) and (II), kits containing these compounds, methods of syntheses, and a method of treatment of a proliferative disease in a subject by administration of a therapeutically effective amount of a compound of formulae (I) or (II). Both classes of compounds were identified through screening of a collection of small molecule libraries.
    本发明涉及式(I)哒嗪酮化合物和式(II)呋喃化合物、式(I)和(II)化合物的药物组合物、含有这些化合物的试剂盒、合成方法以及通过施用治疗有效量的式(I)或(II)化合物治疗受试者增殖性疾病的方法。这两类化合物都是通过筛选一系列小分子化合物库确定的。
  • US7759401B2
    申请人:——
    公开号:US7759401B2
    公开(公告)日:2010-07-20
  • US9562019B2
    申请人:——
    公开号:US9562019B2
    公开(公告)日:2017-02-07
查看更多